Emilie Glad Bak, PhD 🐚
89 posts

Emilie Glad Bak, PhD 🐚
@MicrobeMilo
Microbiome Scientist🙋🏼♀️ Currently on my own👉 Previously 👋 @novozymes @SNIPRbiome @Metabolcenter @SSI_dk @DTU_Bioengineering




Our Copenhagen Gut Microbiome Hub is official 🙌👏 With this initiative we want to support and foster education, research and innovation with respect to #gut microbes 🦠👩🏼🔬🔬 #dkpol #dkvid #dkforsk via.ritzau.dk/pressemeddelel…

Novo Nordisk buys CBMR spinout Embark Biotech, in a deal worth up to €456 million, to acquire their novel approach for treating #obesity and type 2 diabetes! 🚀 “It is a dream come true to have this opportunity to work with Novo Nordisk and strive to transform our discovery into powerful new therapies that could improve the lives of people living with obesity and type 2 diabetes,” says Associate Professor Zach Gerhart-Hines. At CBMR, Associate Professor Zach Gerhart-Hines, together with his former postdoc, Jakob Bondo Hansen and Professor @Thue_Schwartz discovered that by stimulating a single, previously overlooked receptor with carefully designed, long-acting molecules, it was possible to achieve a similar appetite-suppressing outcome as GLP-1 agonists such as @novonordisk's #Wegovy. But in addition, these novel molecules also increased the capacity to burn energy and, importantly, directly improved insulin sensitivity. “I am incredibly proud of being part of this amazing story. A true basic scientific discovery has led to the development of a totally novel therapeutic approach that targets the Holy Grail in diabetes and obesity treatment – energy expenditure and insulin sensitivity. All starting with the establishment of CBMR and the recruitment of Zach and his team 10 years ago,” says Thue W. Schwartz, Scientific Godfather of Embark. Read the full story on the CBMR website 👇 🔗cbmr.ku.dk/news/2023/novo…

Very intense times to work at @UCPH_CPR. Even though it's hard to believe that CPR will close down, it's great to see the determination of everyone to make the best out of the last years.

Deadline extended to March 21st. Join @Pharmabiotic Director and PI @ProfPaulRoss1 and work on his prestigious @ERC_Research funded award to investigate alternatives to #antibiotics . Apply here ore.ucc.ie #research #team



Only 4 days left to apply for the 3-year microbiome bioinformatics postdoc positions available in my group @Metabolcenter Deadline Jan 13th Find details & apply at employment.ku.dk/faculty/?show=… #microbiome #DataScience

The first #MVIF of the new year is in 1⃣week!🥳 ⭐️Keynote talk by @BorkLab Selected talks by ⭐️@WChangzhi ⭐️@HRoager ⭐️@Kenyum_b ⭐️Nitzan Soffer This event is proudly supported by @illumina🙌 Join Gather to discuss their latest technologies! Register shorturl.at/GMPS8

Our review comes from a themed issue on Host-Microbe Interactions: Viruses (eds. @AHarms485 and myself), to be published in the Feb 23 issue of #CurrOpinMicrobiol. Five great papers already online - please go & explore ! sciencedirect.com/journal/curren…



Our biomarker discovery study for liver disease is out in @NatureMedicine today! Plasma proteomics detects early stages of liver disease, outperforming established clinical tests. Great collaboration with @UCPH_CPR, @hustniu, @UniSouthDenmark, @FLASH_OUH nature.com/articles/s4159…

If the microbiome isn’t complex enough already, let’s consider the human gut plasmidome 😀. Lovely work from @SteveStockyPhD et al in the lab. @Pharmabiotic @UccMicrobiology rdcu.be/cOPGX nature.com/articles/s4159…






